Medi-578

DB33744InvestigationalProtein Based Therapies

Medi-578: Overview.

Mechanism: Pharmacologically active on Beta-nerve growth factor
Curator reviewed
Code names: Medi-578

Resolves to

Compound

Targets

What you can answer from here — as of August 28, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Medi-578, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.